Algernon Pharmaceuticals

About:

Algernon Pharmaceuticals company is focused on developing, in-licensing, and commercializing proprietary innovative.

Website: https://algernonpharmaceuticals.com/

Twitter/X: bthbiomedical

Top Investors: MTbrain, Bullrun Capital Inc

Description:

Breathtec Biomedicala medical diagnostics company focused on developing, in-licensing, and commercializing proprietary innovative. Breathtec Biomedical (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Their efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung and breast cancers, neurodegenerative diseases like Alzheimer's, Parkinson's, tuberculosis, diabetes, liver disease, and more.

Total Funding Amount:

$13.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Delta, Ontario, Canada

Founded Date:

2015-01-01

Contact Email:

info(AT)breathtecbiomedical.com

Founders:

Mark Williams

Number of Employees:

1-10

Last Funding Date:

2024-08-07

IPO Status:

Public

Industries:

© 2025 bioDAO.ai